Clinical Trial Update: A Study to Learn More About the Safety of Damoctocog-alfa-pegol When Used in Routine Medical Care in Korean Participants With Hemophilia A

View source ↗

Summary

Bayer is conducting a safety study of damoctocog alfa pegol in Korean participants with Hemophilia A, evaluating safety in routine medical care; the study is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Damoctocog alfa pegol (damoctocog alfa pegol)

Snippet

Sponsor: Bayer | Conditions: Hemophilia A, Prophylaxis of Bleeding | Status: RECRUITING